BiopharmaDirect

Highly Potent Active Pharmaceutical Ingredients

10th May to 11th May 2021,
London, United Kingdom

SMi is delighted to announce its 5th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 10th-11th May 2021.

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along with the increase in associated toxicities, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety. The conference will encompass hot topics including: robotics and automation for containment solutions, cleaning validation, prevention of cross-contamination, strategies for scaling-up, the expanding ADC market beyond oncology.

This year’s event will focus on 4 key themes: best practices for toxicological assessment, innovations in containment and facility design, advances in accelerated ADC production, and environmental considerations for HPAPI manufacture. Key case studies will be highlighted throughout these themes, revealing the key challenges for current HPAPI manufacture, and insights into the latest technological and regulatory advances in this increasingly potent environment.
 

This two-day agenda offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Expand your community and explore the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies form leading pharmaceutical and biotechnology companies.

source: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/Highly-Potent-Active-Pharmaceutical-Ingredients

If you have any questions about this news, please do not hesitate to contact us.